ATE406380T1 - Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen - Google Patents

Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen

Info

Publication number
ATE406380T1
ATE406380T1 AT01961444T AT01961444T ATE406380T1 AT E406380 T1 ATE406380 T1 AT E406380T1 AT 01961444 T AT01961444 T AT 01961444T AT 01961444 T AT01961444 T AT 01961444T AT E406380 T1 ATE406380 T1 AT E406380T1
Authority
AT
Austria
Prior art keywords
vaccines
gag
application
hiv peptides
preserved regions
Prior art date
Application number
AT01961444T
Other languages
English (en)
Inventor
Birger Soerensen
Original Assignee
Bionor Immuno As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionor Immuno As filed Critical Bionor Immuno As
Application granted granted Critical
Publication of ATE406380T1 publication Critical patent/ATE406380T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01961444T 2000-09-04 2001-09-03 Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen ATE406380T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20004413A NO314588B1 (no) 2000-09-04 2000-09-04 HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV

Publications (1)

Publication Number Publication Date
ATE406380T1 true ATE406380T1 (de) 2008-09-15

Family

ID=19911533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01961444T ATE406380T1 (de) 2000-09-04 2001-09-03 Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen

Country Status (19)

Country Link
US (2) US7009037B2 (de)
EP (2) EP1878742A3 (de)
JP (2) JP2004508381A (de)
CN (2) CN1282656C (de)
AR (2) AR033998A1 (de)
AT (1) ATE406380T1 (de)
AU (3) AU8270601A (de)
BR (1) BR0114036A (de)
CA (1) CA2421193A1 (de)
DE (1) DE60135564D1 (de)
EA (1) EA006308B1 (de)
ES (1) ES2312465T3 (de)
HU (1) HUP0303134A3 (de)
MY (1) MY136081A (de)
NO (1) NO314588B1 (de)
NZ (2) NZ535148A (de)
SK (1) SK287917B6 (de)
WO (1) WO2002020554A2 (de)
ZA (1) ZA200301740B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1307130A4 (de) 2000-02-04 2005-01-12 Beth Israel Hospital Impfstoff gegen menschlichen immunschwächevirus
EP2045282B1 (de) * 2005-08-26 2011-03-23 Novo Nordisk A/S Verfahren zur Modifizierung von Polymeren
FI120376B (fi) * 2007-01-17 2009-09-30 Next Biomed Technologies Nbt O Menetelmä biomuokatun, korkean affiniteetin polypeptidin valmistamiseksi
FI120349B (fi) 2007-03-07 2009-09-30 Next Biomed Technologies Nbt O Menetelmä fuusiopolypeptidin valmistamiseksi
EP2344143A1 (de) 2008-09-09 2011-07-20 Mukesh Harilal Shukla Biologisch wirksame zusammensetzung zur behandlung von hiv/aids, herstellungsverfahren und anwendung
WO2010045659A1 (en) 2008-10-17 2010-04-22 American Gene Technologies International Inc. Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
US9733242B2 (en) 2012-10-07 2017-08-15 Sevident, Inc. Devices for capturing analyte
US9910040B2 (en) 2012-07-09 2018-03-06 Sevident, Inc. Molecular nets comprising capture agents and linking agents
FR2957933B1 (fr) * 2010-03-24 2012-04-27 Seppic Sa Vaccin vivant pour maladies aviaires
EP2550362B1 (de) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv-glycoproteine und rekombinante vektoren
US9493514B2 (en) * 2011-01-06 2016-11-15 Bionor Immuno As Dimeric scaffold proteins comprising HIV-1 GP120 and GP41 epitopes
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (de) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunselektion von rekombinantem vesikulärem Stomatitisvirus mit Expression von HIV-1-Proteinen durch Breitbandneutralisierungs-Antikörper
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
JP6310909B2 (ja) * 2012-06-06 2018-04-11 ビオノール イミュノ エーエスＢｉｏｎｏｒ Ｉｍｍｕｎｏ Ａｓ 免疫原及び投薬反応物として使用するためのウイルスタンパク質に由来するペプチド
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
CN105189465B (zh) 2013-03-21 2019-02-26 赛诺菲-安万特德国有限公司 合成含有乙内酰脲的肽产物
WO2014147129A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
EP3072901A1 (de) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
JP6890831B2 (ja) 2015-07-08 2021-06-18 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド Ｈｉｖ予備免疫化および免疫療法
US10137144B2 (en) 2016-01-15 2018-11-27 American Gene Technologies International Inc. Methods and compositions for the activation of gamma-delta T-cells
DK3402483T3 (da) 2016-01-15 2024-01-02 American Gene Tech Int Inc Fremgangsmåder og sammensætninger til aktivering af gamma-delta-T-celler
US10888613B2 (en) 2016-02-08 2021-01-12 American Gene Technologies International Inc. Method of producing cells resistant to HIV infection
DK3426777T3 (da) 2016-03-09 2022-04-25 American Gene Tech Int Inc Kombinationsvektorer og fremgangsmåder til behandling af cancer
US11976292B2 (en) 2016-06-08 2024-05-07 American Gene Technologies International Inc. Non-integrating viral delivery system and methods related thereto
IL284348B2 (en) 2016-07-08 2025-06-01 American Gene Tech Int Inc Hiv pre-immunization and immunotherapy
JP7176756B2 (ja) 2016-07-21 2022-11-22 アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド パーキンソン病を処置するためのウイルスベクター
CA3057142A1 (en) 2017-04-03 2018-10-11 American Gene Technologies International Inc. Compositions and methods for treating phenylketonuria
CA3064442A1 (en) 2017-06-16 2018-12-20 American Gene Technologies International Inc. Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells
US11352646B2 (en) 2018-11-05 2022-06-07 American Gene Technologies International Inc. Vector system for expressing regulatory RNA
RU2727673C1 (ru) * 2019-08-09 2020-07-22 Федеральное государственное унитарное предприятие «Государственный научно-исследовательский институт особо чистых биопрепаратов» Федерального медико-биологического агентства Антитела против белка р17 ВИЧ-1 субтипа А
GB2610556A (en) * 2021-09-02 2023-03-15 113 Botanicals Ltd Extraction

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
SE468168B (sv) 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
DE4039925A1 (de) * 1990-12-14 1992-06-17 Behringwerke Ag Ausgewaehlte peptide des gruppenspezifischen antigens (gag) von humanem immundefizienzvirus (hiv), ihre herstellung und verwendung
SE9101863D0 (sv) * 1991-06-13 1991-06-13 Replico Medical Ab Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
US6525173B1 (en) 1997-01-02 2003-02-25 Universidade Federal De Minas Gerais Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1)
GB9703802D0 (en) * 1997-02-24 1997-04-16 Kingsman Susan M Anti-hiv peptides and proteins
US5972339A (en) * 1997-11-13 1999-10-26 The General Hospital Corporation Method of eliciting anti-HIV-1 helper T cell responses
CA2685270C (en) * 1998-05-13 2014-07-29 Pharmexa Inc. Expression vectors for stimulating an immune response and methods of using the same
NO311807B1 (no) 1999-03-04 2002-01-28 Bionor Immuno As HIV-peptider, antigener, vaksinepreparater, immunoassay- testsett og en metode for påvisning av antistoffer fremkalt av HIV

Also Published As

Publication number Publication date
HUP0303134A2 (hu) 2005-03-29
EA200300336A1 (ru) 2003-08-28
CN1282656C (zh) 2006-11-01
CN1460111A (zh) 2003-12-03
AU2001282706B2 (en) 2007-03-22
AU2007202739A1 (en) 2007-07-05
JP2004508381A (ja) 2004-03-18
AR033998A1 (es) 2004-01-21
DE60135564D1 (de) 2008-10-09
MY136081A (en) 2008-08-29
US20070237783A1 (en) 2007-10-11
HK1059940A1 (en) 2004-07-23
US7009037B2 (en) 2006-03-07
AU2007202739B2 (en) 2009-12-03
EP1322665B1 (de) 2008-08-27
BR0114036A (pt) 2003-07-22
JP2011219481A (ja) 2011-11-04
EP1878742A2 (de) 2008-01-16
NZ524556A (en) 2005-01-28
NO314588B1 (no) 2003-04-14
US7612168B2 (en) 2009-11-03
EP1322665A2 (de) 2003-07-02
EA006308B1 (ru) 2005-10-27
ZA200301740B (en) 2004-06-21
EP1878742A3 (de) 2008-04-30
NO20004413D0 (no) 2000-09-04
WO2002020554A3 (en) 2002-06-13
AU8270601A (en) 2002-03-22
WO2002020554A2 (en) 2002-03-14
US20040115615A1 (en) 2004-06-17
HUP0303134A3 (en) 2012-09-28
NO20004413L (no) 2002-03-05
NZ535148A (en) 2007-06-29
CA2421193A1 (en) 2002-03-14
CN101104636A (zh) 2008-01-16
AR071262A2 (es) 2010-06-09
ES2312465T3 (es) 2009-03-01
SK4022003A3 (en) 2003-09-11
SK287917B6 (sk) 2012-03-02

Similar Documents

Publication Publication Date Title
ATE406380T1 (de) Hiv-peptide aus konservierten regionen in gag p17 und deren anwendung z.b. in impfstoffen
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
BR0115810B1 (pt) composições cosméticas, dermatológicas e farmacêuticas isentas de tensoativos.
TR200202194T2 (tr) Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri
MA27681A1 (fr) Peptides cycliques selectifs.
MXPA02007478A (es) Vacuna contra el virus de inmunodeficiencia humana.
EE200300544A (et) 4-anilinokinoliin-3-karboksamiidid, nende kasutamine ning valmistamine
DE60131432D1 (de) Hiv-peptide aus tat-, rev- und wef-konservierten regionen und deren anwendung z.b. als impfstoffkomponenten
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
IT1321052B1 (it) Perfezionamenti in, o relativi a, attenuatori e dispositiviamplificatori.
EP1456376A4 (de) Neue chimäre rev-, tat- und nef-antigene
DE60113556T2 (de) Applikator, z.b. für rasierpräparate und dergleichen
DE50213606D1 (de) Zylinder im Falzapparat
JP2002275230A5 (de)
GB0217548D0 (en) Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
NO20025209L (no) Cyklipostiner, deres fremstilling og anvendelse
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
DK1423429T3 (da) Antistoffer mod caspase-8 og deres fremstilling og anvendelse
HUP0303423A3 (en) Natural antibody active against hiv virus
ITRM20010029V0 (it) Poltrona perfezionata, in particolare per aeromobili.
RU2001100069A (ru) Антгельминтное средство
ITRM20010670A1 (it) Piante ricombinanti e costrutti di dna.
ES1045336Y (es) Maquina cortadora de raiz y talle de ajos.
ITBS20000130A0 (it) Valvola di aerazione e antiriflusso.
Fox Ancient Two-Legged Lizard Intrigues Scientists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties